PATENT CLAIM ANALYSIS

Application Number: 15895907
Application Type: Utility
Filing Date: 2018-02
Publication Date: 2018-11
Patent Classification: ["424", "185100"]

Abstract:
The present invention claims an isolated nucleotide sequence characterized by encoding the PFR1 protein of  Leishmania infantum  or a fragment thereof. This PFR1 protein or a fragment thereof comprises at least a selected immunodominant epitope between the following group: SEQ ID No: 1, SEQ ID No: 2, SEQ ID No: 3, SEQ ID No: 4, SEQ ID No: 5, SEQ ID No: 6, SEQ ID No: 7 and SEQ ID No: 8, where the immunodominant epitope is able to induce an antigen-specific T cell cytotoxic immune response in an animal, against the kinetoplastids causing the leishmaniasis disease. The immunodominant epitopes are cytotoxic T-lymphocyte activators and they present a high binding affinity for A2 type MHC Class I molecule.

Claim (Index 12):
The method of  claim 11 , wherein the animal is a human or a dog.

Metadata:
- Claim Count in Document: 38.0
- Percentile: 88.0
- Lexical Diversity: 1.74684
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['14234075', '13469636', '12149841', '14780504', '14288361']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7243781854966113
- 35 USC 102 Novelty (BERT): 0.7099703090251459
- Combined Prediction Score: 0.7229373978494648
- Mean Citation Score: 474.7210539999999
- Max Citation Score: 1011.5331
- Similarity Product: 724.0606255600333

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test